Proteomics bags US patent for endometriosis test
AI Summary
Proteomics International Laboratories has secured a US patent for its test diagnosing endometriosis, supporting plans for product rollout in the large US healthcare market. This patent milestone is a critical step in commercializing the diagnostic test.
Proteomics International Laboratories has won a US patent for its endometriosis test, advancing plans to roll out the diagnostic product in the world’s biggest healthcare market.